| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |